Why Harvard Bioscience Stock Rose This Week
Shares of Harvard Bioscience (NASDAQ: HBIO), a medical equipment and technology manufacturer and retailer, were up by 16.4% for the week as of Thursday's close, according to data provided by S&P Global Market Intelligence. Harvard Bioscience sells laboratory equipment to clinical research organizations, pharmaceutical companies, and academic labs -- everything from amino acid analyzers to programmable syringe pumps. The company has two segments: cellular and molecular, and pre-clinical.